Cite
APA Citation
Schmidinger, M., Motzer, R. J., Rolland, F., Staehler, M., Rink, M., Retz, M., Csoszi, T., McCaffrey, J. A., De Giorgi, U., Caserta, C., Duran, I., Benzaghou, F., Clary, D. O., Albiges, L., Choueiri, T. K., & Tannir, N. M. (2022). analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study. Acta oncologica, 61, 52–57. http://access.bl.uk/ark:/81055/vdc_100150517928.0x000053